| 臺大學術典藏 |
2021-03-09T06:46:18Z |
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties
|
Zhang L.;Lau Y.-K.;Xi L.;Ruey-Long Hong;Kim D.S.H.L.;Chen C.-F.;Hortobagyi G.N.;Chang C.-J.;Hung M.-C.; Zhang L.; Lau Y.-K.; Xi L.; RUEY-LONG HONG; Kim D.S.H.L.; Chen C.-F.; Hortobagyi G.N.; Chang C.-J.; Hung M.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:18Z |
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
|
Yeh K.-H.;Cheng A.-L.;Lin M.-T.;Ruey-Long Hong;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Lee P.-H.;Chen Y.-C.; Yeh K.-H.; Cheng A.-L.; Lin M.-T.; RUEY-LONG HONG; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:18Z |
Relation between Histological Intensity of Transforming Growth Factor-�] Isoforms in Human Osteosarcoma and the Rate of Lung Metastasis
|
Yang R.-S.;Wu C.-T.;Lin K.-H.;Ruey-Long Hong;Liu T.-K.;Lin K.-S.; Yang R.-S.; Wu C.-T.; Lin K.-H.; RUEY-LONG HONG; Liu T.-K.; Lin K.-S. |
| 臺大學術典藏 |
2021-03-09T06:46:18Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C.;Yeh K.-H.;Ruey-Long Hong;Yang C.-H.;Lin M.-T.;Chen Y.-C.;Cheng A.-L.; Hsu C.; Yeh K.-H.; RUEY-LONG HONG; Yang C.-H.; Lin M.-T.; Chen Y.-C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
|
Ruey-Long Hong;Tseng Y.-L.;Chang F.-H.; RUEY-LONG HONG; Tseng Y.-L.; Chang F.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?
|
Ruey-Long Hong;Huang C.-J.;Tseng Y.-L.;Pang V.F.;Chen S.-T.;Liu J.-J.;Chang F.-H.; RUEY-LONG HONG; Huang C.-J.; Tseng Y.-L.; Pang V.F.; Chen S.-T.; Liu J.-J.; Chang F.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Ruey-Long Hong;Sheen T.S.;Ko J.Y.;Hsu M.M.;Wang C.C.;Ting L.L.; RUEY-LONG HONG; Sheen T.S.; Ko J.Y.; Hsu M.M.; Wang C.C.; Ting L.L. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model
|
Tseng Y.-L.;Ruey-Long Hong;Tao M.-H.;Chang F.-H.; Tseng Y.-L.; RUEY-LONG HONG; Tao M.-H.; Chang F.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Curcumin inhibits tyrosine kinase activity of p185(neu) and also depletes p185(neu1)
|
Ruey-Long Hong;Spohn W.H.;Hung M.-C.; RUEY-LONG HONG; Spohn W.H.; Hung M.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity
|
Ruey-Long Hong;Tseng Y.-L.; RUEY-LONG HONG; Tseng Y.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M.;Chiou C.-R.;Ko J.-Y.;Sheen T.-S.;Ruey-Long Hong;Ting L.-L.; Hsu M.-M.; Chiou C.-R.; Ko J.-Y.; Sheen T.-S.; RUEY-LONG HONG; Ting L.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M.;Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Sheen T.-S.;Lou P.-J.; Hsu M.-M.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Anaphylaxis after propocol infusion for Port-A-Cath insertion in a 35-year old man
|
Tsai M.-H.;Kuo P.-H.;Ruey-Long Hong;Yang P.-C.; Tsai M.-H.; Kuo P.-H.; RUEY-LONG HONG; Yang P.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Prognostic value of multidrug resistance 1, glutathione-S-transferase-�k and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy
|
Hsu C.-H.;Chen C.-L.;Ruey-Long Hong;Chen K.-L.;Lin J.-F.;Cheng A.-L.; Hsu C.-H.; Chen C.-L.; RUEY-LONG HONG; Chen K.-L.; Lin J.-F.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma
|
Lee Y.-L.;Ye Y.-L.;Yu C.-I.;Wu Y.-L.;Lai Y.-L.;Ku P.-H.;Ruey-Long Hong;Chiang B.-L.; Lee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG; Chiang B.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Hsu M.-M.;Sheen T.-S.;Lou P.-J.;Wang C.-C.;Chung N.-N.;Lui L.T.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
Chie W.-C.;Ruey-Long Hong;Lai C.-C.;Ting L.-L.;Hsu M.-M.; Chie W.-C.; RUEY-LONG HONG; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study
|
Tseng Y.-L.;Liu J.-J.;Ruey-Long Hong; Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluation
|
Liu J.-J.;Ruey-Long Hong;Cheng W.-F.;Hong K.;Chang F.-H.;Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG; Cheng W.-F.; Hong K.; Chang F.-H.; Tseng Y.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis
|
Wu M.-S.;Lee C.-W.;Sheu J.-C.;Shun C.-T.;Wang H.-P.;Ruey-Long Hong;Lee W.-J.;Lin J.-T.; Wu M.-S.; Lee C.-W.; Sheu J.-C.; Shun C.-T.; Wang H.-P.; RUEY-LONG HONG; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
|
Huang S.-Y.;Tang J.-L.;Yao M.;Ko B.-S.;Ruey-Long Hong;Tsai W.;Wang C.-H.;Tien H.-F.;Shen M.-C.;Chen Y.-C.; Huang S.-Y.; Tang J.-L.; Yao M.; Ko B.-S.; RUEY-LONG HONG; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
|
Ruey-Long Hong;Tseng Y.-L.; RUEY-LONG HONG; Tseng Y.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.;Tien H.-F.;Tang J.-L.;Yao M.;Chen Y.-C.;Su I.-J.;Hsu S.-M.;Ruey-Long Hong; Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Ruey-Long Hong;Lin C.-Y.;Ting L.-L.;Ko J.-Y.;Hsu M.-M.; RUEY-LONG HONG; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR Cells
|
Tsai T.;Ruey-Long Hong;Tsai J.-C.;Lou P.-J.;Ling I.-F.;Chen C.-T.; Tsai T.; RUEY-LONG HONG; Tsai J.-C.; Lou P.-J.; Ling I.-F.; Chen C.-T. |
